{
    "nctId": "NCT02485678",
    "briefTitle": "A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer",
    "officialTitle": "A Pragmatic Cluster-Randomized Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer (AToM)",
    "overallStatus": "COMPLETED",
    "conditions": "Early Stage Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 1460,
    "primaryOutcomeMeasure": "Number of Emergency and Hospital (ED+H) visits during chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women 18 years of age or older\n* Diagnosis of early stage (I-III) breast cancer\n* Starting adjuvant or neo-adjuvant chemotherapy within the intervention period at a participating centre\n\nExclusion Criteria:\n\n* Currently participating in a clinical trial involving an investigational agent\n\nInclusion Criteria for PRO Sub-Study\n\n* Willingness to participate in the study and complete PRO questionnaires as required\n* Ability to understand and provide written informed consent\n* Language and literacy skills consistent with completing study questionnaires",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}